Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Immune Observatory was a Boston/Cambridge-based 501(c)(3) nonprofit focused on high-throughput immunological assay development, serology, data science, and mathematical modeling for global immune surveillance. Founded by Michael Mina, the organization aimed to build a large-scale immune observatory capable of tracking population immunity, pathogen exposure, and infectious disease dynamics to improve pandemic preparedness and public health response. Its activities appear to have centered on surveillance infrastructure, testing-related services, and analytical tools rather than a traditional therapeutic drug pipeline. Public records indicate it operated as Immune Observatory Incorporated in Massachusetts and received U.S. tax-exempt recognition in 2020. Third-party records also indicate its federal tax-exempt status was later automatically revoked for non-filing, and there is no clear evidence of an ongoing active operating organization as of 2026.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Immune Observatory.